MFC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Manulife Financial Corp (MFC) is not a strong buy at this moment for a beginner investor with a long-term focus. While the company shows some positive catalysts like a dividend increase and stable earnings, the technical indicators and financial performance suggest caution. The stock is better suited for monitoring until stronger entry signals or improved financial trends emerge.
The MACD is negatively expanding (-0.178), indicating bearish momentum. RSI is neutral at 23.156, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near support levels (S1: 36.14, S2: 35.397), which could limit downside risk. Overall, the technical setup is mixed, leaning slightly bearish.
Q4 core EPS exceeded expectations at C$1.
Announced a 10% dividend increase.
Quarterly dividend payment scheduled for March 19,
Analysts have raised price targets recently, with Scotiabank setting a target of C$55 and CIBC upgrading to Outperformer.
Revenue, net income, and EPS declined YoY in Q4
MACD indicates bearish momentum.
Stock trend analysis predicts a potential short-term decline (-3.21% in the next day, -2.46% in the next week).
In Q4 2025, revenue dropped by -1.75% YoY to CAD 10.07 billion, net income decreased by -9.17% YoY to CAD 1.396 billion, and EPS fell by -5.68% YoY to CAD 0.83. Despite these declines, the company announced a 10% dividend increase, reflecting confidence in its cash flow stability.
Analysts are generally positive on MFC. Scotiabank raised the price target to C$55 with an Outperform rating, and CIBC upgraded the stock to Outperformer with a price target of C$58. Barclays and Morgan Stanley maintain cautious optimism with Equal Weight ratings and price targets of C$52 and $51, respectively.
